Position in NTRA
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$407,175
-$92,999 QoQ
Shares Held
1,500
-40.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#566
of 844 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $6,017,727 across 6 Diagnostics & Research names. NTRA ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
11,279 | $2,148,423 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,690 | $1,348,658 | |
| 3 | LH |
Labcorp Holdings Inc.
|
4,335 | $1,213,800 | |
| 4 | ILMN |
Illumina, Inc.
|
3,970 | $698,045 | |
| 5 | NTRA |
Natera, Inc.
This page
|
1,500 | $407,175 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
383 | $201,626 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $407,175 | 1,500 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $500,174 | 2,501 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $619,917 | 2,706 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||